UCLA researchers developed an AI model using EHR data to better detect undiagnosed Alzheimer's disease, especially in underrepresented groups.
Key Details
- 1The AI leverages semi-supervised positive unlabeled learning to identify probable Alzheimer's cases from electronic health records (EHRs).
- 2Tested on data from over 97,000 UCLA Health patients across multiple ethnic groups.
- 3Achieved 77–81% sensitivity in various populations compared to 39–53% for traditional models.
- 4Model validation included polygenic risk scores (APOE ε4 allele), supporting accuracy of predictions.
- 5Tool addresses underdiagnosis, which especially affects African American and Hispanic/Latino communities.
- 6Planned prospective validation in other health systems; patent application filed for framework.
Why It Matters
AI-driven detection of undiagnosed Alzheimer's may support earlier intervention, which is critical as new treatments emerge. Importantly, this model addresses equity concerns by reducing diagnostic bias across diverse populations, a key consideration for both clinical and AI application in healthcare.
Source
EurekAlert
Related News
•EurekAlert
FDA Approves Johns Hopkins AI Tool for Early Sepsis Detection
FDA clears an AI-driven system developed by Johns Hopkins to detect sepsis up to 48 hours earlier and reduce mortality rates.
•EurekAlert
New AI Vision-Language Model Enhances Chest CT Diagnostics
Researchers developed an interpretable AI model that uses visual question answering to generate detailed diagnostic findings from chest CT scans, aimed at improving lung cancer diagnosis.
•EurekAlert
Optical AI Chip Boosts Real-Time Dry Eye Gland Diagnosis Accuracy
A new metasurface spectral AI chip enables rapid, accurate diagnosis of meibomian gland dysfunction (MGD) from tissue samples, achieving 96.22% accuracy.